Allovir Inc
General ticker "ALVR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $55.4M
Allovir Inc does not follow the US Stock Market performance with the rate: -5.4%.
Estimated limits based on current volatility of 5.0%: low 0.43$, high 0.48$
Factors to consider:
- Current price 54.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.01$, 3.04$]
- 2024-12-30 to 2025-12-30 estimated range: [1.21$, 3.36$]
Financial Metrics affecting the ALVR estimates:
- Negative: Non-GAAP EPS, $ of -1.84 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -37.51 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term ALVR quotes
Long-term ALVR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $169.82MM | $171.20MM | $181.33MM |
| Operating Income | $-169.82MM | $-171.20MM | $-181.33MM |
| Non-Operating Income | $-1.14MM | $2.23MM | $-9.21MM |
| R&D Expense | $120.73MM | $118.87MM | $133.07MM |
| Income(Loss) | $-170.96MM | $-168.97MM | $-190.54MM |
| Taxes | $1.01MM | $-0.27MM | $-0.13MM |
| Profit(Loss) | $-171.96MM | $-168.71MM | $-190.42MM |
| Stockholders Equity | $225.27MM | $224.52MM | $145.78MM |
| Inventory | $0.05MM | $0.16MM | $0.00MM |
| Assets | $286.59MM | $277.08MM | $190.80MM |
| Operating Cash Flow | $-106.32MM | $-142.05MM | $-124.45MM |
| Capital expenditure | $0.03MM | $0.10MM | $0.00MM |
| Investing Cash Flow | $185.98MM | $-80.48MM | $37.98MM |
| Financing Cash Flow | $0.23MM | $126.96MM | $70.50MM |
| Earnings Per Share* | $-2.74 | $-2.20 | $-1.83 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.